Skip to main content

Advertisement

Log in

Human ESC vs. iPSC—Pros and Cons

  • Innovation, Translation, Education
  • Published:
Journal of Cardiovascular Translational Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Aoi, T., Yae, K., Nakagawa, M., et al. (2008). Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science DOI 10.1126/science.1154884.

  2. Hanna, J., Wernig, M., Markoulaki, S., et al. (2007). Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science, 318(5858), 1920–1923.

    Article  PubMed  CAS  Google Scholar 

  3. Maherali, N. (2007). Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell, 1, 55–70.

    Article  PubMed  CAS  Google Scholar 

  4. Nakagawa, M., Koyanagi, M., Tanabe, K., et al. (2008). Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nature Biotechnology, 26(1), 101–106.

    Article  PubMed  CAS  Google Scholar 

  5. Okita, K., Ichisaka, T., & Yamanaka, S. (2007). Generation of germ line-competent induced pluripotent stem cells. Nature, 448(7151), 313–317.

    Article  PubMed  CAS  Google Scholar 

  6. Takahashi, K., Tanabe, K., Ohnuki, M., et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131(5), 861–872.

    Article  PubMed  CAS  Google Scholar 

  7. Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126(4), 663–676.

    Article  PubMed  CAS  Google Scholar 

  8. Wernig, M., Meissner, A., Foreman, R., et al. (2007). In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature, 448(7151), 318–324.

    Article  PubMed  CAS  Google Scholar 

  9. Yu, J., Vodyanik, M. A., Smuga-Otto, K., et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science, 318(5858), 1917–1920.

    Article  PubMed  CAS  Google Scholar 

  10. Lowry, W. E., Richter, L., Yachechko, R., et al. (2007). Generation of human induced pluripotent stem cells from dermal fibroblasts. Proceedings of the National Academy of Sciences of the United States of America, 105(8), 2883–2888.

    Article  Google Scholar 

  11. Park, I.-H., Zhao, R., West, J., et al. (2008). Reprogramming of human somatic cells to pluripotency with defined factors. Nature, 451, 141–146.

    Article  PubMed  CAS  Google Scholar 

  12. Simonsson, S., & Gurdon, J. (2004). DNA demethylation is necessary for the epigenetic reprogramming of somatic cell nuclei. Nature Cell Biology, 6(10), 984–990.

    Article  PubMed  CAS  Google Scholar 

  13. Jiang, G., Park, K., Kim, J., et al. (2008). Hyaluronic acid–polyethyleneimine conjugate for target specific intracellular delivery of siRNA. Biopolymers, 89(7), 635–642 Jul.

    Article  PubMed  CAS  Google Scholar 

  14. Toh, M. L., Hong, S. S., van de Loo, F., et al. (2005). Enhancement of adenovirus-mediated gene delivery to rheumatoid arthritis synoviocytes and synovium by fiber modifications: role of arginine–glycine–aspartic acid (RGD)- and non-RGD-binding integrins. Journal of Immunology, 175(11), 7687–7698 Dec 1.

    CAS  Google Scholar 

  15. Cowan, C. A., Klimanskaya, I., McMahon, J., et al. (2004). Derivation of embryonic stem-cell lines from human blastocysts. New England Journal of Medicine, 350(13), 1353–1356.

    Article  PubMed  CAS  Google Scholar 

  16. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282(5391), 1145–1147.

    Article  PubMed  CAS  Google Scholar 

  17. Taylor, C. J., Bolton, E. M., Pocock, S., Sharples, L. D., Pedersen, R. A., & Bradley, J. A. (2005). Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet, 366(9502), 2019–2025.

    Article  PubMed  Google Scholar 

  18. Revazova, E. S., Turovets, N. A., Kochetkova, O. D., et al. (2008). HLA homozygous stem cell lines derived from human parthenogenetic blastocysts. Cloning and Stem Cells, 10(1), 11–24.

    Article  PubMed  CAS  Google Scholar 

  19. Addis, R. C., Bulte, J. W., & Gearhart, J. D. (2008). Special cells, special considerations: the challenges of bringing embryonic stem cells from the laboratory to the clinic. Clinical Pharmacology & Therapeutics, 83(3), 386–389.

    Article  CAS  Google Scholar 

  20. Allegrucci, C., & Young, L. E. (2007). Differences between human embryonic stem cell lines. Human Reproduction Update, 13(2), 103–120.

    Article  PubMed  CAS  Google Scholar 

  21. Huber, I., Itzhaki, I., Caspi, O., et al. (2007). Identification and selection of cardiomyocytes during human embryonic stem cell differentiation. FASEB Journal, 21(10), 2551–2563.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgement

The authors wish to thank James Byrne, Ph.D. (Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Palo Alto, CA) and Zeina Saikali, Ph.D. (Juravinski Cancer Centre, Hamilton, Ontario, Canada), for having kindly reviewed the manuscript. The authors also wish to thank Kathleen Gallagher and Brian Habekoss, for having provided excellent administrative support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Phillip C. Yang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pappas, J.J., Yang, P.C. Human ESC vs. iPSC—Pros and Cons. J. of Cardiovasc. Trans. Res. 1, 96–99 (2008). https://doi.org/10.1007/s12265-008-9032-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12265-008-9032-2

Navigation